Evidence map›Paper›PMID 40125193›Full record

ArticleCureus2025

Cavernous Hemangioma: A Rare Adrenal Tumor Associated With Hyperaldosteronism.

Hannah Sage, Edward Jones, Vladimir Neychev

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hannah SageSurgery, University of Central Florida College of Medicine, Orlando, USA.
Edward JonesPathology, AdventHealth Orlando, Orlando, USA.
Vladimir NeychevSurgery, University of Central Florida College of Medicine, Orlando, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenal cavernous hemangiomas are rare benign venous malformations characterized by vascular dysmorphogenesis. A 53-year-old male patient was referred for a surgical consultation with a 5 cm heterogeneous, lipid-poor, incidental left adrenal mass. It was detected on a computed tomography (CT) scan performed for left upper quadrant pain. His past medical history was significant for poorly-controlled hypertension on a multi-drug regimen, anxiety, headaches, insomnia, and palpitations. Laboratory testing performed by his primary care physician revealed elevated plasma catecholamines, which were concerning for pheochromocytoma. A repeat workup by endocrinology and endocrine surgery showed biochemical evidence of primary hyperaldosteronism with an aldosterone/plasma renin ratio of 36.8 and normal plasma catecholamines and metanephrines. Due to the biochemical workup, size, and radiological features of the mass, a decision to proceed with a left adrenalectomy was made. The patient was started on phenoxybenzamine two weeks before surgery due to a high index of clinical suspicion for a pheochromocytoma, despite the equivocal biochemical workup. Surgical pathology revealed a cavernous hemangioma with pseudonodular thickening of the adrenal cortex without evidence of malignancy, adrenal adenoma, or pheochromocytoma. On follow-up, the patient was on fewer antihypertensive medications with normal blood pressure and a normalized aldosterone/plasma renin ratio. A diagnosis of cavernous hemangioma should be considered for adrenal masses of uncertain biology and biochemical activity.

Indexed as

adrenal gland neoplasmsadrenal lesionadrenal pheochromocytomaadrenal surgerycavernous hemangioma surgery

Identifiers

PMID40125193
PMCPMC11929149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.